{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T05:17:22Z","timestamp":1790054242534,"version":"4.0.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,5,19]],"date-time":"2017-05-19T00:00:00Z","timestamp":1495152000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.jneuroim.2017.05.010","type":"journal-article","created":{"date-parts":[[2017,5,19]],"date-time":"2017-05-19T20:32:28Z","timestamp":1495225948000},"page":"51-57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Autoantibodies as diagnostic biomarkers for the detection and subtyping of multiple sclerosis"],"prefix":"10.1016","volume":"309","author":[{"given":"Cassandra","family":"DeMarshall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric L.","family":"Goldwaser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhirup","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George A.","family":"Godsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nimish K.","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2093-8093","authenticated-orcid":false,"given":"Umashanger","family":"Thayasivam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin A.","family":"Belinka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert G.","family":"Nagele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jneuroim.2017.05.010_bb0005","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1007\/s00415-010-5863-2","article-title":"Glial fibrillary acidic protein: a potential biomarker for progression in multiple sclerosis","volume":"258","author":"Axelsson","year":"2011","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2017.05.010_bb0010","first-page":"111","article-title":"Making the diagnosis of multiple sclerosis","volume":"98","author":"Birnbaum","year":"2006","journal-title":"Adv. Neurol."},{"issue":"Pt 6","key":"10.1016\/j.jneuroim.2017.05.010_bb0015","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1093\/brain\/123.6.1174","article-title":"Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation","volume":"123","author":"Bitsch","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2017.05.010_bb0020","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1023\/A:1010933404324","article-title":"Random forests","volume":"45","author":"Breiman","year":"2001","journal-title":"Mach. Learn."},{"issue":"1\u20132","key":"10.1016\/j.jneuroim.2017.05.010_bb0025","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jneuroim.2009.07.017","article-title":"Serum anti-GAGA4 IgM antibodies differentiate relapsing remitting and secondary progressive multiple sclerosis from primary progressive multiple sclerosis and other neurological diseases","volume":"217","author":"Brettschneider","year":"2009","journal-title":"J. Neuroimmunol."},{"issue":"9313","key":"10.1016\/j.jneuroim.2017.05.010_bb0030","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S0140-6736(02)08220-X","article-title":"Multiple sclerosis","volume":"359","author":"Compston","year":"2002","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.jneuroim.2017.05.010_bb0035","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.autrev.2015.07.014","article-title":"Peripheral blood biomarkers in multiple sclerosis","volume":"14","author":"D'Ambrosio","year":"2015","journal-title":"Autoimmun. Rev."},{"issue":"Suppl. 1","key":"10.1016\/j.jneuroim.2017.05.010_bb0040","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1016\/S0022-510X(09)71301-2","article-title":"Prognosis of the individual course of disease: the elements of time, heterogeneity and precision","volume":"287","author":"Daumer","year":"2009","journal-title":"J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.jneuroim.2017.05.010_bb0045","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.imlet.2015.09.010","article-title":"Potential utility of autoantibodies as blood-based biomarkers for early detection and diagnosis of Parkinson's disease","volume":"168","author":"DeMarshall","year":"2015","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.jneuroim.2017.05.010_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.irn.2015.05.005","article-title":"Utility of autoantibodies as biomarkers for diagnosis and staging of neurodegenerative diseases","volume":"122","author":"DeMarshall","year":"2015","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.jneuroim.2017.05.010_bb0055","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.dadm.2016.03.002","article-title":"Detection of Alzheimer's disease at mild cognitive impairment and disease progression using autoantibodies as blood-based biomarkers","volume":"3","author":"DeMarshall","year":"2016","journal-title":"Alzheimers Dement. (Amst)"},{"issue":"4","key":"10.1016\/j.jneuroim.2017.05.010_bb0060","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00401-006-0045-0","article-title":"Protein co-expression with axonal injury in multiple sclerosis plaques","volume":"111","author":"Diaz-Sanchez","year":"2006","journal-title":"Acta Neuropathol."},{"issue":"3","key":"10.1016\/j.jneuroim.2017.05.010_bb0065","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1080\/17843286.2016.1147675","article-title":"Rare onset symptoms in multiple sclerosis","volume":"71","author":"Evlice","year":"2016","journal-title":"Acta Clin. Belg."},{"issue":"4","key":"10.1016\/j.jneuroim.2017.05.010_bb0070","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1177\/1352458508101944","article-title":"Anti-alpha-glucose-based glycan IgM antibodies predict relapse activity in multiple sclerosis after the first neurological event","volume":"15","author":"Freedman","year":"2009","journal-title":"Mult. Scler."},{"issue":"4","key":"10.1016\/j.jneuroim.2017.05.010_bb0075","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1600-0404.2007.00872.x","article-title":"Anti-myelin antibodies in clinically isolated syndrome indicate the risk of multiple sclerosis in a Swiss cohort","volume":"116","author":"Greeve","year":"2007","journal-title":"Acta Neurol. Scand."},{"issue":"5","key":"10.1016\/j.jneuroim.2017.05.010_bb0080","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/ene.13274","article-title":"Neurofilament light chain in cerebrospinal fluid and prediction of disease activity in clinically isolated syndrome and relapsing-remitting multiple sclerosis","volume":"24","author":"Hakansson","year":"2017","journal-title":"Eur. J. Neurol."},{"issue":"2","key":"10.1016\/j.jneuroim.2017.05.010_bb0085","doi-asserted-by":"crossref","first-page":"e32383","DOI":"10.1371\/journal.pone.0032383","article-title":"Diagnosis of Parkinson's disease based on disease-specific autoantibody profiles in human sera","volume":"7","author":"Han","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.jneuroim.2017.05.010_bb0090","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/1756285613488434","article-title":"Sex and gender issues in multiple sclerosis","volume":"6","author":"Harbo","year":"2013","journal-title":"Ther. Adv. Neurol. Disord."},{"issue":"6","key":"10.1016\/j.jneuroim.2017.05.010_bb0095","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s40291-014-0117-0","article-title":"Biomarkers of therapeutic response in multiple sclerosis: current status","volume":"18","author":"Harris","year":"2014","journal-title":"Mol. Diagn. Ther."},{"issue":"1","key":"10.1016\/j.jneuroim.2017.05.010_bb0100","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1136\/jnnp-2014-308984","article-title":"Overlapping CNS inflammatory diseases: differentiating features of NMO and MS","volume":"86","author":"Jurynczyk","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"5","key":"10.1016\/j.jneuroim.2017.05.010_bb0105","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s00415-008-0778-x","article-title":"Clinical characteristics of patients with late-onset multiple sclerosis","volume":"255","author":"Kis","year":"2008","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2017.05.010_bb0110","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.brainres.2010.05.038","article-title":"Brain-reactive autoantibodies are nearly ubiquitous in human sera and may be linked to pathology in the context of blood-brain barrier breakdown","volume":"1345","author":"Levin","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.jneuroim.2017.05.010_bb0115","doi-asserted-by":"crossref","first-page":"41473","DOI":"10.1038\/srep41473","article-title":"Kynurenine pathway metabolomics predicts and provides mechanistic insight into multiple sclerosis progression","volume":"7","author":"Lim","year":"2017","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.jneuroim.2017.05.010_bb0120","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/01376517-199306000-00007","article-title":"Multiple sclerosis: a literature review","volume":"25","author":"Miller","year":"1993","journal-title":"J. Neurosci. Nurs."},{"issue":"4","key":"10.1016\/j.jneuroim.2017.05.010_bb0125","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3233\/JAD-2011-110098","article-title":"Brain-reactive autoantibodies prevalent in human sera increase intraneuronal amyloid-beta(1\u201342) deposition","volume":"25","author":"Nagele","year":"2011","journal-title":"J. Alzheimers Dis."},{"issue":"8","key":"10.1016\/j.jneuroim.2017.05.010_bb0130","doi-asserted-by":"crossref","first-page":"e23112","DOI":"10.1371\/journal.pone.0023112","article-title":"Diagnosis of Alzheimer's disease based on disease-specific autoantibody profiles in human sera","volume":"6","author":"Nagele","year":"2011","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.jneuroim.2017.05.010_bb0135","doi-asserted-by":"crossref","first-page":"e60726","DOI":"10.1371\/journal.pone.0060726","article-title":"Natural IgG autoantibodies are abundant and ubiquitous in human sera, and their number is influenced by age, gender, and disease","volume":"8","author":"Nagele","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2017.05.010_bb0140","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1002\/ana.410360718","article-title":"Clinical scoring methods for multiple sclerosis","volume":"36","author":"Noseworthy","year":"1994","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.jneuroim.2017.05.010_bb0145","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000330750","article-title":"A blood-based algorithm for the detection of Alzheimer's disease","volume":"32","author":"O'Bryant","year":"2011","journal-title":"Dement. Geriatr. Cogn. Disord."},{"issue":"1\u20132","key":"10.1016\/j.jneuroim.2017.05.010_bb0150","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000345605","article-title":"Molecular neuropsychology: creation of test-specific blood biomarker algorithms","volume":"37","author":"O'Bryant","year":"2014","journal-title":"Dement. Geriatr. Cogn. Disord."},{"issue":"2","key":"10.1016\/j.jneuroim.2017.05.010_bb0155","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00401-011-0840-0","article-title":"The neuropathological basis of clinical progression in multiple sclerosis","volume":"122","author":"Reynolds","year":"2011","journal-title":"Acta Neuropathol."},{"issue":"6","key":"10.1016\/j.jneuroim.2017.05.010_bb0160","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1177\/1352458516634871","article-title":"Aging and multiple sclerosis","volume":"22","author":"Sanai","year":"2016","journal-title":"Mult. Scler."},{"issue":"3","key":"10.1016\/j.jneuroim.2017.05.010_bb0165","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1177\/1352458514522104","article-title":"To look for a needle in a haystack: the search for autoantibodies in multiple sclerosis","volume":"20","author":"Schirmer","year":"2014","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2017.05.010_bb0170","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.nicl.2017.01.029","article-title":"New rapid, accurate T2 quantification detects pathology in normal-appearing brain regions of relapsing-remitting MS patients","volume":"14","author":"Shepherd","year":"2017","journal-title":"Neuroimage Clin."},{"issue":"2","key":"10.1016\/j.jneuroim.2017.05.010_bb0175","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJMoa1110740","article-title":"Potassium channel KIR4.1 as an immune target in multiple sclerosis","volume":"367","author":"Srivastava","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.jneuroim.2017.05.010_bb0180","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1177\/1352458507077622","article-title":"Anti-myelin antibodies predict the clinical outcome after a first episode suggestive of MS","volume":"13","author":"Tomassini","year":"2007","journal-title":"Mult. Scler."},{"issue":"2","key":"10.1016\/j.jneuroim.2017.05.010_bb0185","doi-asserted-by":"crossref","first-page":"e321","DOI":"10.1212\/NXI.0000000000000321","article-title":"Metabolomic signatures associated with disease severity in multiple sclerosis","volume":"4","author":"Villoslada","year":"2017","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572817301406?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572817301406?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:29:26Z","timestamp":1759048166000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572817301406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":37,"alternative-id":["S0165572817301406"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2017.05.010","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoantibodies as diagnostic biomarkers for the detection and subtyping of multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2017.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}